Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer
AssigneeResearch Institute for Nutrition and Aging Co., Ltd.
InventorsKunihiko Kiyono, Kenji Onishi, Yasuharu Nagahama, Takashi Watanabe
Life of this patent
Estimating the term…
Abstract
Provided is a novel medicament capable of reducing the side effects of metformin or a pharmaceutically acceptable salt thereof and useful as an anti-malignant tumor agent, in which metformin or a pharmaceutically acceptable salt thereof and dihydroquercetin or a pharmaceutically acceptable salt thereof are combined.
Claims2
A method enhancing an anti-malignant tumor action of metformin or a pharmaceutically acceptable salt thereof, comprising administering to a patient with a malignant tumor dihydroquercetin or a pharmaceutically acceptable salt thereof,
- wherein the malignant tumor is lung cancer, liver cancer, bile duct cancer, pancreatic cancer, prostate cancer, breast cancer, or ovarian cancer.
A method of enhancing an anti-malignant tumor action, comprising administering to a patient with a malignant tumor dihydroquercetin or a pharmaceutically acceptable salt thereof, in combination with metformin or a pharmaceutically acceptable salt thereof,
- wherein the malignant tumor is lung cancer, liver cancer, bile duct cancer, pancreatic cancer, prostate cancer, breast cancer, or ovarian cancer.
Dependencies are inferred from the claim text.